Infliximab Associated New-Onset Psoriasis
February 2006 | Volume 5 | Issue 2 | Case Reports | 178 | Copyright © February 2006
David R. Adams MD PharmD, Tamy Buckel MD, Jennifer A. Sceppa MD
Abstract
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We
report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease
experienced new onset, biopsy confirmed psoriasis. 
